Get the Stockscreener App
1.18
0.85%
-0.00
Aptevo Therapeutics Inc stock is traded at $1.18, with a volume of 363.97K.
It is down -0.85% in the last 24 hours and down -23.03% over the past month.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
See More
Previous Close:
$1.18
Open:
$1.19
24h Volume:
363.97K
Relative Volume:
0.07
Market Cap:
$19.81M
Revenue:
$12.99M
Net Income/Loss:
$-23.72M
P/E Ratio:
-0.0121
EPS:
-97.2514
Net Cash Flow:
$-23.28M
1W Performance:
-11.36%
1M Performance:
-23.03%
6M Performance:
-78.76%
1Y Performance:
-99.49%
1-Day Range:
$1.15
$1.2199
1-Week Range:
$1.04
$1.31
52-Week Range:
$1.04
$298.00
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Name
Aptevo Therapeutics Inc
Sector
Industry
Phone
206-838-0500
Address
2401 4TH AVE., SEATTLE, WA
Compare APVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.1758 | 19.88M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.20 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.88 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.18 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
908.04 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.44 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-05-17 | Resumed | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Stock (APVO) Latest News
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
D pipelineMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Aptevo Therapeutics Inc. stock benefit from AI adoption2025 Pullback Review & Low Risk Growth Stock Ideas - newser.com
How Aptevo Therapeutics Inc. stock reacts to oil pricesAnalyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
What macro factors could drive Aptevo Therapeutics Inc. (AP81) stock higherJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research
Why Aptevo Therapeutics Inc. stock remains a top recommendationEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Can Aptevo Therapeutics Inc. (AP81) stock sustain breakout momentumWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Why ETFs are accumulating Aptevo Therapeutics Inc. (AP81) stockTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com
How Aptevo Therapeutics Inc. (AP81) stock behaves under inflation pressure - newser.com
Combining machine learning predictions for Aptevo Therapeutics Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Aptevo Therapeutics Inc. stock chart pattern explainedTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How to escape a deep drawdown in Aptevo Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com
Smart tools for monitoring Aptevo Therapeutics Inc.’s price actionInflation Watch & Real-Time Buy Signal Alerts - newser.com
Using R and stats models for Aptevo Therapeutics Inc. forecastingTrade Exit Report & Safe Capital Growth Plans - newser.com
Is Aptevo Therapeutics Inc. stock bottoming out2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Is Aptevo Therapeutics Inc. still worth holding after the dipMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Trend analysis for Aptevo Therapeutics Inc. this weekJuly 2025 Levels & Precise Buy Zone Identification - newser.com
Can Aptevo Therapeutics Inc. recover in the next quarterJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
How to integrate Aptevo Therapeutics Inc. into portfolio analysis toolsTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Can Aptevo Therapeutics Inc. stock hit analyst price targetsJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Aptevo Therapeutics Inc Stock (APVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):